Latest & greatest articles for atrial fibrillation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on atrial fibrillation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on atrial fibrillation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for atrial fibrillation

761. Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery (IPG121)

Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery (IPG121) Overview | Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery | Guidance | NICE Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery Interventional procedures guidance [IPG121] Published date: May 2005 Share Save Guidance The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS (...) in England, Wales, Scotland and Northern Ireland on radiofrequency ablation for atrial fibrillation in association with other cardiac surgery. Description Atrial fibrillation is the irregular and rapid beating of the upper two chambers of the heart (the atria). It may be classified as paroxysmal, persistent or permanent. Patients with atrial fibrillation may be asymptomatic or they may have symptoms including palpitations, dizziness and breathlessness. They also have an increased risk of stroke

2005 National Institute for Health and Clinical Excellence - Interventional Procedures

762. Amiodarone versus sotalol for atrial fibrillation. (Abstract)

Amiodarone versus sotalol for atrial fibrillation. The optimal pharmacologic means to restore and maintain sinus rhythm in patients with atrial fibrillation remains controversial.In this double-blind, placebo-controlled trial, we randomly assigned 665 patients who were receiving anticoagulants and had persistent atrial fibrillation to receive amiodarone (267 patients), sotalol (261 patients), or placebo (137 patients) and monitored them for 1 to 4.5 years. The primary end point was the time (...) to recurrence of atrial fibrillation beginning on day 28, determined by means of weekly transtelephonic monitoring.Spontaneous conversion occurred in 27.1 percent of the amiodarone group, 24.2 percent of the sotalol group, and 0.8 percent of the placebo group, and direct-current cardioversion failed in 27.7 percent, 26.5 percent, and 32.1 percent, respectively. The median times to a recurrence of atrial fibrillation were 487 days in the amiodarone group, 74 days in the sotalol group, and 6 days

2005 NEJM Controlled trial quality: predicted high

763. Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial. Full Text available with Trip Pro

Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial. Although left atrial radiofrequency ablation (RFA) is increasingly used for the treatment of chronic atrial fibrillation during mitral valve surgery, its efficacy to restore sinus rhythm and any resulting benefits have not been examined in the context of an adequately powered randomized trial.To determine whether intraoperative RFA of the left atrium increases (...) the long-term restoration of sinus rhythm and improves exercise capacity.Randomized, double-blind trial performed in a single UK tertiary referral center with enrollment between December 2001 and November 2003. A total of 101 patients referred for mitral valve surgery with at least 6 months' history of uninterrupted atrial fibrillation were assessed for eligibility; 97 were enrolled. Patients were followed up for 12 months.Patients were randomly assigned to undergo mitral valve surgery and RFA

2005 JAMA Controlled trial quality: predicted high

764. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. Full Text available with Trip Pro

Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. Treatment with antiarrhythmic drugs and anticoagulation is considered first-line therapy in patients with symptomatic atrial fibrillation (AF). Pulmonary vein isolation (PVI) with radiofrequency ablation may cure AF, obviating the need for antiarrhythmic drugs and anticoagulation.To determine whether PVI is feasible as first-line therapy for treating patients

2005 JAMA Controlled trial quality: uncertain

765. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study

A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study A randomised controlled trial (...) and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study Hobbs F D R, Fitzmaurice D A, Mant J, Murray E, Jowett S, Bryan S, Raftery J, Davies M, Lip G Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation

2005 Health Technology Assessment (HTA) Database.

766. Radiofrequency catheter ablation technique in atrial fibrillation

Radiofrequency catheter ablation technique in atrial fibrillation Radiofrequency catheter ablation technique in atrial fibrillation Radiofrequency catheter ablation technique in atrial fibrillation Pichon Riviere A, Augustovski F, Ferrante D, Regueiro A, Garcia Marti S, Glujovsky D, Lopez A Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation (...) Pichon Riviere A, Augustovski F, Ferrante D, Regueiro A, Garcia Marti S, Glujovsky D, Lopez A. Radiofrequency catheter ablation technique in atrial fibrillation. Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Informe de Respuesta Rapida No.47. 2005 Authors' objectives This study aims to assess the usefulness of radiofrequency ablation in the management of atrial fibrillation. Authors' conclusions At present, radiofrequency ablation shows promising results in those

2005 Health Technology Assessment (HTA) Database.

767. Cryoablation for atrial fibrillation in association with other cardiac surgery

Cryoablation for atrial fibrillation in association with other cardiac surgery Cryoablation for atrial fibrillation in association with other cardiac surgery Cryoablation for atrial fibrillation in association with other cardiac surgery National Institute for Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation National Institute for Clinical (...) Excellence. Cryoablation for atrial fibrillation in association with other cardiac surgery. London: National Institute for Clinical Excellence (NICE) 2005: 2 Authors' objectives This study aims to assess the current evidence on cryoablation for atrial fibrillation in association with other cardiac surgery. Authors' conclusions 1.1 Current evidence on the safety and efficacy of cryoablation for atrial fibrillation in association with other cardiac surgery appears adequate to support the use

2005 Health Technology Assessment (HTA) Database.

768. Microwave ablation for atrial fibrillation in association with other cardiac surgery

Microwave ablation for atrial fibrillation in association with other cardiac surgery Microwave ablation for atrial fibrillation in association with other cardiac surgery Microwave ablation for atrial fibrillation in association with other cardiac surgery National Institute for Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation National Institute (...) for Clinical Excellence. Microwave ablation for atrial fibrillation in association with other cardiac surgery. London: National Institute for Clinical Excellence (NICE) 2005: 2 Authors' objectives This study aims to assess the current evidence on microwave ablation for atrial fibrillation in association with other cardiac surgery. Authors' conclusions 1.1 Current evidence on the safety and efficacy of microwave ablation for atrial fibrillation in association with other cardiac surgery appears adequate

2005 Health Technology Assessment (HTA) Database.

769. Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery

Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery National Institute for Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation (...) National Institute for Clinical Excellence. Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery. London: National Institute for Clinical Excellence (NICE) 2005: 2 Authors' objectives This study aims to assess the current evidence on radiofrequency ablation for atrial fibrillation in association with other cardiac surgery. Authors' conclusions 1.1 Current evidence on the safety and efficacy of radiofrequency ablation (RFA) for atrial fibrillation in association

2005 Health Technology Assessment (HTA) Database.

770. Dronedarone hydrochloride in atrial fibrillation - horizon scanning review

Dronedarone hydrochloride in atrial fibrillation - horizon scanning review Dronedarone hydrochloride in atrial fibrillation - horizon scanning review Dronedarone hydrochloride in atrial fibrillation - horizon scanning review NHSC Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NHSC. Dronedarone hydrochloride in atrial fibrillation (...) - horizon scanning review. Birmingham: National Horizon Scanning Centre (NHSC). 2005 Authors' objectives This study aims to assess the effectiveness of dronedarone hydrochloride in atrial fibrillation (AF). Authors' conclusions Dronedarone hydrochloride (SR33589B) is an antiarrhythmic drug in phase III trials to prevent recurrence of atrial fibrillation (AF) and to control ventricular rate. It is structurally similar to amiodarone but reportedly has a better adverse effect and drug interaction profile

2005 Health Technology Assessment (HTA) Database.

771. [Catheter ablation of atrial fibrillation - early assessment briefs (Alert)]

[Catheter ablation of atrial fibrillation - early assessment briefs (Alert)] Kateterburen ablationsbehandling vid formaksflimmer [Catheter ablation of atrial fibrillation - early assessment briefs (Alert)] Kateterburen ablationsbehandling vid formaksflimmer [Catheter ablation of atrial fibrillation - early assessment briefs (Alert)] Swedish Council on Technology Assessment in Health Care Record Status This is a bibliographic record of a published health technology assessment from a member (...) of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Swedish Council on Technology Assessment in Health Care. Kateterburen ablationsbehandling vid formaksflimmer. [Catheter ablation of atrial fibrillation - early assessment briefs (Alert)] Stockholm: The Swedish Council on Health Technology Assessment (SBU). SBU Alert report no: 2005-02. 2005 Authors' objectives This review aims to assess the effectiveness of catheter ablation therapy in curing atrial

2005 Health Technology Assessment (HTA) Database.

772. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. Full Text available with Trip Pro

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. In patients with nonvalvular atrial fibrillation, warfarin prevents ischemic stroke, but dose adjustment, coagulation monitoring, and bleeding limit its use.To compare the efficacy of the oral direct thrombin inhibitor ximelagatran with warfarin for prevention of stroke and systemic embolism.Double-blind, randomized, multicenter trial (2000-2001) conducted at 409 North American (...) sites, involving 3922 patients with nonvalvular atrial fibrillation and additional stroke risk factors.Adjusted-dose warfarin (aiming for an international normalized ratio [INR] 2.0 to 3.0) or fixed-dose oral ximelagatran, 36 mg twice daily.The primary end point was all strokes (ischemic or hemorrhagic) and systemic embolic events. The primary analysis was based on demonstrating noninferiority within an absolute margin of 2.0% per year according to the intention-to-treat model.During 6405 patient

2005 JAMA Controlled trial quality: predicted high

773. Meta-analysis of clinical outcomes of maze-related surgical procedures for medically refractory atrial fibrillation

Meta-analysis of clinical outcomes of maze-related surgical procedures for medically refractory atrial fibrillation Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

774. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis

Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

775. Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery

Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery DiDomenico R J, Massad M G CRD summary This review found that treatments for preventing atrial fibrillation after heart surgery were effective, but no single drug was shown to be consistently superior. The main recommendations were (...) the use of beta-blockers, unless contraindicated, and the treatment of electrolyte deficiencies. Those at higher risk should also receive amiodarone or sotalol. There were some problems with the methodology used in the review. Authors' objectives To evaluate pharmacological strategies for preventing atrial fibrillation (AF) after open heart surgery. Searching MEDLINE was searched from 1966 to November 2003; the search terms were given. The reference lists of identified papers were checked. Only peer

2005 DARE.

776. Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat

Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

777. Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis

Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

778. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

779. Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and meta-analysis

Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

780. Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis

Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.